drugset / Trial / NCT03391882
A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
RandomizedCrossoverOpen-labelTreatment
Summary
A study of an investigational drug to see how it affects the people with Parkinson's Disease complicated by motor fluctuations ("OFF" Episodes) compared to an approved drug used to treat people with Parkinson's Disease complicated by motor fluctuations ("OFF" Episodes)
Timeline
- Start
- 2018-12-19
- Primary completion
- 2021-08-11
- Completion
- 2021-08-11
Outcome
Missed primary endpoint
registry analysis (superiority test); SC (Subcutaneous Apomorphine) vs APL (APL-130277); p = 0.8944; Mean Difference (Final Values) 0.23 (95% CI -3.16 to 3.62) NCT03391882 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | APL-130277 | Unknown | — | Other |
| Comparator | Apomorphine | Unknown | — | Subcutaneous |